Matterworks develops AI-based analytical tools for biological research and biotechnology.
Founded in 2019 and based in Somerville, Massachusetts, Matterworks develops AI tools for biological research, bioprocessing and biomarker discovery. Its products include the Large Spectral Model for omics analysis, Pyxis for mass spectrometry analysis and cloud-based data processing applications. In June 2025, it raised an undisclosed amount in Series A funding co-led by Lewis & Clark Ventures and OMX Ventures, with participation from Germin8 Ventures, Intermountain Ventures, Pillar Companies and Tarsadia Investments.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in